Sort By

Myasthenia Gravis Approved Drugs

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Myasthenia Gravis.

Found 3 Approved Drugs for Myasthenia Gravis

Pyridostigmine

Brand Names
Pryidostigmine, Mestinon, Regonol
Form: Injection, Tablet, Solution
Method of administration: Oral, Intravenous, Parenteral
FDA approval date: April 06, 1955
Classification: Cholinesterase Inhibitor
INDICATION: MESTINON is useful in the treatment of myasthenia gravis.

Soliris

Generic Name
Eculizumab
Form: Injection
Method of administration: Intravenous
FDA approval date: April 02, 2007
Classification: Complement Inhibitor
Soliris is a complement inhibitor indicated for: The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis.

Pralidoxime

Brand Names
Protopam, DuoDote
Form: Injection, Kit
Method of administration: Intravenous, Subcutaneous, Intramuscular
FDA approval date: March 10, 1965
Classification: Cholinesterase Reactivator
DuoDote is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides in adults and pediatric patients weighing more than 41 kg (90 pounds). DuoDote, a combination of atropine, a cholinergic muscarinic antagonist, and pralidoxime chloride, a cholinesterase reactivator, is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides in adults and pediatric patients weighing more than 41 kg (90 pounds). ( 1 )
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances